Trial Profile
Phase II Single Arm Trial of FOLF(HA)Iri Plus Cetuximab in Irinotecan-naïve Second Line Patients With KRAS Wild Type Metastatic Colorectal Cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Irinotecan hyaluronic acid complex (Primary) ; Cetuximab; Fluorouracil; Folinic acid; Irinotecan; Levofolinic acid
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms CHIME
- 01 May 2014 New trial record